Input 2020.12.31 10:21
In his New Year’s speech, Director Kim said, “Many overseas vaccines, domestically developed vaccines and antibody treatments, etc., which are introduced to be introduced, operate a product-specific evaluation team, and review data that can be reviewed before applying for permission to secure and verify the safety and effectiveness review period. I will.”
He said, “In the case of national shipment approval, which is the final quality confirmation procedure before vaccine shipment, we will support rapid shipment by establishing test methods in advance, so that safe vaccines and treatments will be supplied as soon as possible.” “We will create an environment in which the public can receive vaccinations with peace of mind by transparently disclosing information on permits and abnormal cases at home and abroad to ensure strict compliance until vaccination.”
Deputy Director Kim also said, “We will actively support the early development of diagnostic products so that the people can quickly and accurately diagnose infectious diseases, as well as continue to verify the safety and effectiveness of the diagnostic reagents currently used.”
Finally, he emphasized the safety of food and medical products.
“Considering the increase in consumption per person due to non-face-to-face with Corona 19, we will strengthen distribution management for online food sales and delivery operations, and thoroughly manage overseas direct purchase products,” said “building a tight safety net for high-quality medical products. I will.”